Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000068

Chief Operating Officer sold 13,449 shares at an average $17.92 ($240,941)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jarrett Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-18 Sale : show line 1 in the form 10b5-1 −12,153 $17.84 $216,810 228,100 D
2024-03-18 Sale : show line 2 in the form 10b5-1 −1,296 $18.62 $24,132 226,804 D
Open-market sales · 13,449 sh · avg $17.92 · $240,941
Loading xslF345X05/wk-form4_1710965959.xml…